The results of several studies have demonstrated that women and men with a cancer diagnosis benefit from interventions to reduce distress and improve quality of life (QOL). However, little is known about the costs and effectiveness of such interventions.

Healthcare is becoming more complex across all disciplines, at all levels, and throughout the world. As a result, practicing medicine that emphasizes the value received from an intervention is increasingly essential to the long-term sustainability of the healthcare delivery model.

The value of drugs, whether individually or comparatively, and the definition of value itself, have emerged as acute concerns in oncology, where the cost of cancer care has evoked issues of financial toxicity. In the United States alone, the costs associated with cancer treatment have been forecast to increase 27% from their 2010 levels, to approximately $157.8 billion by 2020.

Hyperkalemia, which is defined as an elevated serum potassium level (ie, >5.0 mEq/L), may be caused by a reduction in the renal excretion of potassium or an intracellular-to-extracellular shift in potassium that results from various acute clinical conditions. Although the kidney can adjust to a reduced number of nephrons and maintain normokalemia under steady-state conditions, it lacks the ability to respond to acute increases in potassium load and to adequately excrete potassium in patients with chronic kidney disease (CKD); the result in both cases is hyperkalemia.

In recent years, several health plans in the Health Insurance Marketplace exchange were offering free doctors’ visits to their members, with the hope of identifying illnesses before they become more difficult or more expensive to treat.

Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults, with a prevalence of approximately 0.6% in the United States. RA has a significant negative impact on health-related quality of life and imposes a substantial economic burden on the US healthcare system.

Rheumatoid arthritis (RA) is a chronic inflammatory disease that is typically accompanied by swelling, tenderness of the joints, and destruction of the synovial joints. The progression of RA can cause disability and can have serious physical, mental, and economic consequences for patients.

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease of unknown cause that primarily affects the peripheral joints in a symmetric pattern. RA’s effect on other areas of the body, including the skin, heart, lungs, and eyes, can be substantial.